Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).

被引：0
|
作者：
Meng, Xue
Zheng, Anping
Wang, Jun
Wang, Jianhua
Li, Guang
Zhu, Jun
Ma, Hu
Zhu, Xiaodong
Shi, Anhui
Dai, Chunhua
Yan, Senxiang
Wang, Buhai
Qu, Zhongyu
Han, Chun
Sun, Xindong
Ye, Ming
Fan, Ruitai
Huerxidan, Ni Yazi
Wang, Xiaohong
Yu, Jinming
机构：
[1] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Anyang Canc Hosp, Anyang, Peoples R China
[3] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou, Peoples R China
[5] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China
[6] Jiangsu Canc Hosp, Nanjing, Peoples R China
[7] Zunyi Med Univ, Affiliated Hosp 2, Zunyi, Guizhou, Peoples R China
[8] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China
[9] Beijing Canc Hosp, Beijing, Peoples R China
[10] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[11] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[12] Northern Jiangsu Peoples Hosp, Yangzhou, Peoples R China
[13] Henan Prov Nanyang Cent Hosp, Nanyang, Peoples R China
[14] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[15] Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[16] Shandong Acad Med Sci, Jinan, Peoples R China
[17] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[18] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[19] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China
[20] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[21] Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4016
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wu, Xiaoyuan
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Niyazi
    Wang, Xiaohong
    Yu, Jinming
    BRITISH JOURNAL OF CANCER, 2023, 129 (11) : 1787 - 1792
  • [2] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Xue Meng
    Anping Zheng
    Jun Wang
    Xiaoyuan Wu
    Guang Li
    Jun Zhu
    Hu Ma
    Xiaodong Zhu
    Anhui Shi
    Chunhua Dai
    Senxiang Yan
    Buhai Wang
    Zhongyu Qu
    Chun Han
    Xindong Sun
    Ming Ye
    Ruitai Fan
    Niyazi Huerxidan
    Xiaohong Wang
    Jinming Yu
    British Journal of Cancer, 2023, 129 : 1787 - 1792
  • [3] Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.
    Jiang, P.
    Wei, L.
    Zou, L.
    Li, X.
    Wang, C.
    Sun, X.
    Ding, L.
    Yuan, X.
    Cheng, H.
    Wu, D.
    Cai, R.
    Yin, R.
    Zhang, J.
    Qiu, H.
    Wang, T.
    Gao, K.
    Zhuo, Y.
    Zhang, Y.
    Zhao, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S518 - S519
  • [4] An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial
    Yu, J.
    Wang, J. H.
    Sun, X. D.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S309 - S309
  • [5] Alternating chemo-radiotherapy versus partly accelerated radiotherapy in advanced squamous cell carcinoma of the head and neck: Results of phase III randomized trial
    Corvo, R
    Benasso, M
    Sanguineti, G
    Lionetto, R
    Numico, G
    Bacigalupo, A
    Ricci, I
    Margarino, G
    Grimaldi, A
    Chiarlone, R
    Merlano, M
    Vitale, V
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 3 - 3
  • [6] Concomittant chemo-radiotherapy versus radiotherapy in advanced (stage III & IV) squamous cell carcinoma of head and neck: results of a prospective trial
    Gupta, A
    Dullu, V
    Paul, J
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 459 - 459
  • [7] Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
    Sun, Yan
    Hu, Chaosu
    Lin, Qin
    Gao, Li
    Wang, Jianhua
    Zhu, Xiaodong
    Hao, Junfang
    Lang, Jin Yi
    Wang, Peiguo
    Ye, Ming
    Li, Xia
    Xu, Benhua
    Wu, Rong
    Bai, Chunmei
    You, Qingshan
    Chen, Xiaozhong
    Wang, Jun
    Hu, Desheng
    Wu, Gang
    Pan, Jian-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    LUNG CANCER, 2005, 49 : S166 - S167
  • [9] Neoadjuvant nivolumab plus paclitaxel/cisplatin- chemo-radiotherapy (neo-NTP-CRT) followed by esophagectomy for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II study
    Huang, Ta-Chen
    Guo, Jhe-Cyuan
    Lin, Chia-Chi
    Kuo, Hung-Yang
    Chuang, Chien Huai
    Jason
    Cheng, Chia-Hsien
    Hsu, Feng-Ming
    Lee, Jang-Ming
    Huang, Pei-Ming
    Ko, Kuan-Yin
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
    Tao, Y.
    Auperin, A.
    Blanchard, P.
    Alfonsi, M.
    Sun, X-S.
    Rives, M.
    Pointreau, Y.
    Castelli, J.
    Graff, P.
    Kam, S. Wong Hee
    Thariat, J.
    Veresezan, O.
    Cornely, A.
    Casiraghi, O.
    Lapeyre, M.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2018, 29
1234